α-Casein (90-95) is a peptide fragment of α-Casein.
CAT No: R1761
CAS No:83471-50-5
Synonyms/Alias:Arg-tyr-leu-gly-tyr-leu;83471-50-5;alpha-Casein (90-95);alpha-Casein(90-95);(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid;-Casein (90-95);DTXSID301003450;HY-P1793;DA-79156;FC108579;CS-0095735;L-Arginyl-L-tyrosyl-L-leucylglycyl-L-tyrosyl-L-leucine;(6S,9S,12S,18S,21S)-1,6-diamino-9,18-bis(4-hydroxybenzyl)-1-imino-12,21-diisobutyl-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosan-22-oic acid;N-{14,19-Diamino-1,4,7,10,13-pentahydroxy-2,11-bis[(4-hydroxyphenyl)methyl]-19-imino-8-(2-methylpropyl)-3,6,9,12,18-pentaazanonadeca-3,6,9,12-tetraen-1-ylidene}leucine;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.